Skoči na glavni sadržaj

Cardiologia Croatica, Vol. 19 No. 11-12, 2024.

Sažetak sa skupa

https://doi.org/10.15836/ccar2024.625

Rhythm disorders in patients after a transcatheter aortic valve replacement procedure

Matko Filipović orcid id orcid.org/0000-0003-0233-2108 ; Dubrava University Hospital, Zagreb, Croatia
Jurica Kotarac orcid id orcid.org/0009-0001-7062-6231 ; Dubrava University Hospital, Zagreb, Croatia
Lucija Mičik orcid id orcid.org/0000-0002-9650-4451 ; Dubrava University Hospital, Zagreb, Croatia
Matija Vrbanić orcid id orcid.org/0000-0002-3229-9436 ; Dubrava University Hospital, Zagreb, Croatia
Andreja Virt orcid id orcid.org/0000-0002-0442-4025 ; Dubrava University Hospital, Zagreb, Croatia
Biljana Hržić orcid id orcid.org/0000-0001-5441-0900 ; Dubrava University Hospital, Zagreb, Croatia
Marina Budetić orcid id orcid.org/0000-0002-1165-7097 ; Dubrava University Hospital, Zagreb, Croatia
Kristijana Radić ; Dubrava University Hospital, Zagreb, Croatia
Ivica Benko orcid id orcid.org/0000-0002-1878-0880 ; Dubrava University Hospital, Zagreb, Croatia

Puni tekst: engleski pdf 137 Kb

str. 625-625

preuzimanja: 104

citiraj

Preuzmi JATS datoteku

Sažetak

Ključne riječi

atrial fibrillation; transcatheter aortic valve replacement complications; pacemaker implantation; conduction disturbances

Hrčak ID:

328961

URI

https://hrcak.srce.hr/328961

Datum izdavanja:

13.12.2024.

Posjeta: 273 *

Copyright statement: Croatian Cardiac Society

Copyright: 2024, Croatian Cardiac Society

Date received: 11 October 2024

Date: 31 October 2024

Publication date: November 2024

Publication date: November 2024

Volume: 19

Issue: 11-12

Page: 625

Publisher ID: CC 2024 19_11-12_625

DOI: 10.15836/ccar2024.625

Article Information (continued)

Categories:

Subject: Extended Abstract

Categories:

Subject: Arrhythmias

KEYWORDS: :

KEYWORDS:

Keyword: atrial fibrillation

Keyword: transcatheter aortic valve replacement complications

Keyword: pacemaker implantation

Keyword: conduction disturbances

Rhythm disorders in patients after a transcatheter aortic valve replacement procedure

[https://orcid.org/0000-0003-0233-2108] Matko Filipović[1][*]

[https://orcid.org/0009-0001-7062-6231] Jurica Kotarac[1]

[https://orcid.org/0000-0002-9650-4451] Lucija Mičik[1]

[https://orcid.org/0000-0002-3229-9436] Matija Vrbanić[1]

[https://orcid.org/0000-0002-0442-4025] Andreja Virt[1]

[https://orcid.org/0000-0001-5441-0900] Biljana Hržić[1]

[https://orcid.org/0000-0002-1165-7097] Marina Budetić[1]

[https://orcid.org/0000-0002-6098-254X] Kristijana Radić[1]

[https://orcid.org/0000-0002-1878-0880] Ivica Benko[1][2]

 

[1] Dubrava University Hospital, Zagreb, Croatia

[2] University of Applied Health Sciences, Zagreb, Croatia

Author notes:

Correspondence to: [*] ADDRESS FOR CORRESPONDENCE: Matko Filipović, Klinička bolnica Dubrava, Avenija Gojka Šuška 6, HR-10000, Zagreb, Croatia. / Phone: +385-99-3046-800 / E-mail: mfilipovic@kbd.hr

Transcatheter Aortic Valve Replacement (TAVI) is a minimally invasive procedure increasingly used to treat severe aortic stenosis, particularly in high-risk patients. However, a notable complication following TAVI is the occurrence of arrhythmias, including new-onset atrial fibrillation (AF) and conduction disturbances requiring permanent pacemaker implantation. The incidence of new-onset AF following TAVI is clinically significant. According to Jilaihawi et al. (2019) (1), AF occurs in approximately 10-15% of patients post-TAVI, with a considerable impact on outcomes. (1) New-onset AF increases the risk of ischemic stroke, heart failure, and prolonged hospital stay. The predictors for AF after TAVI include older age, pre-existing heart conditions, and procedural factors like valve size and positioning. Management strategies focus on anticoagulation therapy to mitigate stroke risk and optimize rate or rhythm control to enhance patient outcomes. Chakravarty et al. (2017) highlight that one of the most frequent conduction disturbances after TAVI is atrioventricular block, leading to the need for permanent pacemaker implantation. (2) Pacemaker implantation rates vary depending on the type of valve used, with some studies showing rates as high as 20-30%. The need for a pacemaker is associated with increased morbidity, including longer hospital stays and a higher risk of heart failure. Risk factors for pacemaker implantation include pre-existing right bundle branch block, extensive calcification of the aortic valve, and deeper valve implantation during the procedure. In summary, the management of rhythm disturbances post-TAVI, including new-onset AF and conduction blocks requiring pacemakers, is essential for improving patient outcomes. Early identification of high-risk patients and adopting tailored therapeutic approaches are crucial for minimizing complications.

LITERATURE

1 

Ryan T, Grindal A, Jinah R, Um KJ, Vadakken ME, Pandey A, et al. New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. JACC Cardiovasc Interv. 2022 March 28;15(6):603–13. https://doi.org/10.1016/j.jcin.2022.01.018 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/35331452

2 

Alperi A, Rodés-Cabau J, Simonato M, Tchetche D, Charbonnier G, Ribeiro HB, et al. Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry. J Am Coll Cardiol. 2021 May 11;77(18):2263–73. https://doi.org/10.1016/j.jacc.2021.03.228 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/33958122

This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.